Winter SF, Jo J, Schiff D, Dietrich J. Central nervous system complications among oncology patients. Hematol Oncol Clin North Am. 2022;36:217–36.

Article  PubMed  Google Scholar 

Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–85.

Article  PubMed  Google Scholar 

Kline-Quiroz C, Nori P, Stubblefield MD. Cancer rehabilitation: acute and chronic issues, nerve injury, radiation sequelae, surgical and chemo-related, Part 1. Med Clin North Am. 2020;104:239–50.

Article  PubMed  Google Scholar 

Alessi I, Caroleo AM, de Palma L, Mastronuzzi A, Pro S, Colafati GS, Boni A, Della Vecchia N, Velardi M, Evangelisti M, Carboni A. Short and long-term toxicity in pediatric cancer treatment: central nervous system damage. Cancers. 2022;14(6):1540.

Dietrich J, Winter SF, Parsons MW. Delayed neurologic complications of brain tumor therapy. In: Tonn J-C, Reardon DA, Rutka JT, Westphal M, editors. Oncology of CNS Tumors. Cham: Springer International Publishing; 2019. p. 751–67.

Chapter  Google Scholar 

Dietrich J, Gondi V, Metha M. Delayed complications of cranial irradiation. UpToDate. 2018.

Gibson EM, Monje M. Microglia in cancer therapy-related cognitive impairment. Trends Neurosci. 2021;44(6):441–51.

Belka C, Budach W, Kortmann RD, Bamberg M. Radiation induced cns toxicity - molecular and cellular mechanisms. Br J Cancer. 2001:1233–9.

• Turnquist C, Harris BT, Harris CC. Radiation-induced brain injury: current concepts and therapeutic strategies targeting neuroinflammation. Neurooncol Adv. 2020;2. Comprehensive review outlining the mechanisms of radiation-induced brain injury, including the role of neuroinflammation and reduced hippocampal neurogenesis.

Scaringi C, Agolli L, Minniti G. Technical advances in radiation therapy for brain tumors. Anticancer Res. 2018;38:6041–5.

Article  CAS  PubMed  Google Scholar 

Diehl CD, Halasz LM, Wilkens JJ, Grosu AL, Combs SE. The role of particle therapy for the treatment of skull base tumors and tumors of the central nervous system (CNS). Top Magn Reson Imaging. 2019;28:49–61.

Article  PubMed  Google Scholar 

Combs SE. Proton and carbon ion therapy of intracranial gliomas. Prog Neurol Surg. 2018;32:57–65.

Article  PubMed  Google Scholar 

Chambrelant I, Eber J, Antoni D, Burckel H, Noël G, Auvergne R, et al. Proton therapy and gliomas: a systematic review. Radiation. 2021;1:218–33.

Article  Google Scholar 

Gondi V, Yock TI, Mehta MP. Proton therapy for paediatric CNS tumours - improving treatment-related outcomes. Nat Rev Neurol. 2016;12:334–45.

Article  CAS  PubMed  Google Scholar 

Weber DC, Lim PS, Tran S, Walser M, Bolsi A, Kliebsch U, Beer J, Bachtiary B, Lomax T, Pica A. Proton therapy for brain tumours in the area of evidence-based medicine. Brit J Radiol. 2020;93(1107):20190237.

Ahmed SK, Brown PD, Foote RL. Protons vs photons for brain and skull base tumors. Semin Radiat Oncol. 2018;28:97–107.

Article  PubMed  Google Scholar 

• Tabrizi S, Yeap BY, Sherman JC, Nachtigall LB, Colvin MK, Dworkin M, et al. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma. Radiother Oncol. 2019;137:95–101. Prospective study of 20 patients with low-grade glioma treated with proton therapy, reporting stable cognitive and neuroendocrine function up to 5 years post-radiotherapy.

Article  PubMed  PubMed Central  Google Scholar 

van der Weide HL, Kramer MCA, Scandurra D, Eekers DBP, Klaver YLB, Wiggenraad RGJ, et al. Proton therapy for selected low grade glioma patients in the Netherlands. Radiotherapy and Oncology. 2021;154:283–90.

Article  PubMed  Google Scholar 

Arvold ND, Niemierko A, Broussard GP, Adams J, Fullerton B, Loeffler JS, Shih HA. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma. Int J Radiat Oncol Biol Phys. 2012;83(4):e495–500.

•• Mohan R, Liu AY, Brown PD, Mahajan A, Dinh J, Chung C, et al. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons. Neuro Oncol. 2021;23:284–94. Randomized phase II trial in patients with glioblastoma treated with either proton- or photon-based therapy, identifying reduced occurrence of radiation-induced grade 3+ lymphopenia following proton therapy given less brain volume exposed to intermediate- and low-dose radiation.

Article  CAS  PubMed  Google Scholar 

Huang J, Dewees TA, Badiyan SN, Speirs CK, Mullen DF, Fergus S, et al. Clinical and dosimetric predictors of acute severe lymphopenia during radiation therapy and concurrent temozolomide for high-grade glioma. Int J Radiat Oncol Biol Physi. 2015;92:1000–7.

Article  CAS  Google Scholar 

Grossman SA, Ye X, Lesser G, Sloan A, Carraway H, Desideri S, et al. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide. Clin Cancer Res. 2011;17:5473–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grassberger C, Hong TS, Hato T, Yeap BY, Wo JY, Tracy M, et al. Differential association between circulating lymphocyte populations with outcome after radiotherapy in subtypes of liver cancer. Int J Radiat Oncol Biol Phys. 2018;101:1222.

Article  PubMed  PubMed Central  Google Scholar 

Yovino S, Grossman SA. Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas. CNS Oncol. 2012;1:149–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grassberger C, Ellsworth SG, Wilks MQ, Keane FK, Loeffler JS. Assessing the interactions between radiotherapy and antitumour immunity. Nat Rev Clin Oncol. 2019;16:729–45.

Article  PubMed  Google Scholar 

Damen PJJ, Kroese TE, van Hillegersberg R, Schuit E, Peters M, Verhoeff JJC, et al. The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2021;111:936–48.

Article  PubMed  Google Scholar 

Vaios EJ, Winter SF, Muzikansky A, Nahed BV, Dietrich J. Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma. Neurooncol Adv. 2020;2:1–11.

Google Scholar 

Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT. Bone marrow drives central nervous system regeneration after radiation injury. J Clin Investig. 2018;128(1):281–93.

Wilke C, Grosshans D, Duman J, Brown P, Li J. Radiation-induced cognitive toxicity: Pathophysiology and interventions to reduce toxicity in adults. Neuro Oncol. 2018;20:597–607.

Article  CAS  PubMed  Google Scholar 

Makale MT, McDonald CR, Hattangadi-Gluth JA, Kesari S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat Rev Neurol. 2017;13:52–64.

Article  CAS  PubMed  Google Scholar 

Wick W, Hertenstein A, Platten M. Neurological sequelae of cancer immunotherapies and targeted therapies. Lancet Oncol. Lancet Publishing Group. 2016:e529–41.

Winter SF, Vaios EJ, Dietrich J. Central nervous system injury from novel cancer immunotherapies. Curr Opin Neurol. 2020;33(6):723–35.

Levin WP, Kooy H, Loeffler JS, DeLaney TF. Proton beam therapy. Br J Cancer. 2005;93:849–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miralbell R, Lomax A, Cella L, Schneider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002;54:824–9.

Article  PubMed  Google Scholar 

Wilson RR. Radiological use of fast protons. Radiology. 1946;47:487–91.

Article  CAS  PubMed  Google Scholar 

Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol. 1999;44:185–205.

Article  CAS  PubMed  Google Scholar 

Grosshans DR, Duman JG, Gaber MW, Sawakuchi G. Particle radiation induced neurotoxicity in the central nervous system. Int J Part Ther. 2018;5:74.

Article  PubMed  PubMed Central  Google Scholar 

• Harrabi SB, von Nettelbladt B, Gudden C, Adeberg S, Seidensaal K, Bauer J, et al. Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma – how safe are protons? Radiother Oncol. 2021;167:211–8. Prospective study of 110 patients with low-grade glioma treated with proton therapy, observing a 21% incidence of mostly clinically silent radiation-induced contrast-enhancing lesions (median follow-up 39 months) with predominant localization at the distal beam end, correlating to areas of high linear energy transfer.

Article  PubMed  Google Scholar 

Ilicic K, Combs SE, Schmid TE. New insights in the relative radiobiological effectiveness of proton irradiation. Radiat Oncol. 2018;13(1):1–8.

Kaiser J, Bledowski C, Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex. 2014;54:33–50.

Article  PubMed  Google Scholar 

Ricard D, Durand T, Tauziède-Espariat A, Leclercq D, Psimaras D. Neurologic complications of radiation therapy. In: Schiff D, Arrillaga I, Wen PY, editors. Cancer neurology in clinical practice: neuro-logical complications of cancer and its treatment. 3rd ed. Springer International: Publishing; 2017. p. 241–73.

DeAngelis LM, Delattre JY, Posner JB. Radiation-induced dementia in patients cured of brain metastases. Neurology. 1989;39(6):789–9.

Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037–44.

Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18:1049–60.

Article  PubMed  PubMed Central  Google Scholar 

Jalali R, Gupta T, Goda JS, Goswami S, Shah N, Dutta D, et al. Efficacy of stereotactic conformal radiotherapy vs conventional radiotherapy on benign and low-grade brain tumors: A randomized clinical trial. JAMA Oncol. 2017;3:1368–76.

Article  PubMed  PubMed Central  Google Scholar 

Klein M, Heimans JJ, Aaronson NK, Van Der Ploeg HM, Grit J, Muller M, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet. 2002;360:1361–8.

Article  CAS  PubMed  Google Scholar 

Correa DD, DeAngelis LM, Shi W, Thaler HT, Lin M, Abrey LE. Cognitive functions in low-grade gliomas: disease and treatment effects. J Neurooncol. 2007;81:175–84.

Article  PubMed  Google Scholar 

Kiehna EN, Mulhern RK, Li C, Xiong X, Merchant TE. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol. 2006;24:5283–90.

Article  PubMed  Google Scholar 

Valk PE, Dillon WP. Radiation injury of the brain. AJNR Am J Neuroradiol. 1991;12:45–62.

CAS  PubMed  PubMed Central  Google Scholar 

Karschnia P, Parsons MW, Dietrich J. Pharmacologic management of cognitive impairment induced by cancer therapy. Lancet Oncol. 2019;20(2):e92–e102.